#1 Clinical Trials Search in Europe

Cholesterol

This article explores the use of cholesterol in clinical trials for various medical conditions. Researchers are investigating cholesterol supplementation as a potential treatment for genetic disorders like Smith-Lemli-Opitz Syndrome (SLOS) and as part of combination therapies for certain cancers. These studies aim to understand how cholesterol metabolism affects disease progression and whether manipulating cholesterol levels can improve patient outcomes.

Table of Contents

What is Cholesterol?

Cholesterol is a waxy substance that is essential for various bodily functions. While it’s often associated with heart disease when levels are too high, cholesterol is actually crucial for building cell membranes, producing hormones, and aiding in digestion. In some medical conditions, cholesterol can be used as a treatment to address deficiencies or metabolic disorders[1].

Cholesterol in Smith-Lemli-Opitz Syndrome (SLOS) Treatment

One of the primary uses of cholesterol as a treatment is for a rare genetic disorder called Smith-Lemli-Opitz Syndrome (SLOS). SLOS is caused by a defect in cholesterol production, leading to a deficiency of this important substance in the body[1][2].

Patients with SLOS may experience various symptoms, including:

  • Growth failure: Difficulty in gaining weight and growing at a normal rate
  • Intellectual disability: Challenges with learning and cognitive development
  • Behavioral disorders: Including autism-like behaviors
  • Progressive retinal dystrophy: Gradual deterioration of the retina, which can affect vision
  • Hearing loss: Varying degrees of hearing impairment
  • Photosensitivity: Increased sensitivity to light
  • Multiple birth defects: Including abnormalities of the heart, lungs, brain, gastrointestinal tract, limbs, genitalia, and kidneys

Cholesterol supplementation is used to treat SLOS by addressing the underlying deficiency. The goal is to increase cholesterol levels in the body, which may help improve some symptoms and support overall growth and development[5].

Cholesterol in Other Medical Conditions

While SLOS is the primary condition where cholesterol is used as a treatment, research is ongoing to explore its potential benefits in other areas:

  • Cone-Rod Dystrophy: A group of inherited eye disorders that affect the retina[1]
  • Hearing Loss: Particularly in relation to SLOS[2]

It’s important to note that in these cases, cholesterol is used to treat deficiencies, not high cholesterol levels that are commonly associated with heart disease.

How is Cholesterol Administered?

Cholesterol treatment can be administered in several ways:

  • Cholesterol suspension: An oil-based liquid form of cholesterol that can be taken orally[5]
  • Dietary sources: Foods high in cholesterol, such as eggs, may be recommended as part of the treatment[2]
  • Slo-lesterol: A specific formulation of cholesterol used in some treatments[2]

The dosage is typically based on the patient’s age, weight, and initial cholesterol levels. The goal is to increase and maintain cholesterol levels within a normal range[5].

Ongoing Research and Clinical Trials

Several clinical trials are underway to better understand the effects of cholesterol supplementation in SLOS and related conditions. These studies aim to:

  • Evaluate the long-term effects of cholesterol treatment on growth, development, and specific symptoms of SLOS[1]
  • Assess the impact of cholesterol supplementation on retinal function and hearing[1]
  • Investigate the combination of cholesterol with antioxidant treatments to potentially improve outcomes[1]
  • Study the genetic factors involved in SLOS and how they relate to treatment response[2]

Potential Side Effects and Monitoring

While cholesterol supplementation is generally considered safe for patients with SLOS, regular monitoring is essential. Doctors typically perform the following tests:

  • Blood tests to measure cholesterol and its precursor levels[1]
  • Liver and kidney function tests[1]
  • Vitamin D levels (to prevent toxicity when combined with certain antioxidants)[1]
  • Growth and development assessments[5]
  • Eye exams and hearing tests[1]

It’s crucial for patients or caregivers to follow the prescribed treatment plan closely and attend all scheduled follow-up appointments to ensure the best possible outcomes and minimize any potential risks.

Aspect Details
Main Conditions Studied Smith-Lemli-Opitz Syndrome (SLOS), Pancreatic Adenocarcinoma, HDL Metabolism Disorders
Cholesterol Interventions Cholesterol supplementation, Cholesterol-lowering drugs (in cancer studies)
Additional Treatments Antioxidants (for SLOS), Combination with standard chemotherapy (for cancer)
Key Outcome Measures Changes in cholesterol levels, Growth and development, Retinal function, Hearing ability, Tumor response
Safety Monitoring Regular blood tests, Monitoring of adverse events
Innovative Approaches Use of radiolabeled cholesterol to study reverse cholesterol transport, Combination of cholesterol manipulation with cancer treatment

FAQ

  • What is Smith-Lemli-Opitz Syndrome (SLOS)? SLOS is a genetic disorder caused by an abnormality in cholesterol production. It is associated with multiple birth defects, mental retardation, and various organ abnormalities. Patients with SLOS typically have cholesterol deficiency.
  • How is cholesterol being used to treat SLOS? Researchers are using cholesterol supplementation to treat SLOS patients. This involves providing additional cholesterol through diet or medication to increase cholesterol levels and potentially improve growth, mental development, and overall health.
  • Are there any other treatments being studied alongside cholesterol for SLOS? Yes, some studies are combining cholesterol supplementation with antioxidant medications. The goal is to prevent retinal degeneration, hearing problems, and skin issues associated with SLOS.
  • How is cholesterol being studied in cancer research? In some cancer studies, researchers are exploring the use of cholesterol-lowering drugs in combination with standard chemotherapy. The idea is that reducing cholesterol availability might slow down or stop the progression of certain cancers, such as pancreatic adenocarcinoma.
  • What are some of the outcomes being measured in these clinical trials? Researchers are measuring various outcomes, including changes in cholesterol levels, growth and development in SLOS patients, retinal function, hearing ability, and tumor response in cancer patients. They also monitor for any side effects or safety concerns related to the treatments.

Ongoing Clinical Trials on Cholesterol

  • Study on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Belgium Czechia France Greece Hungary Latvia +3

Glossary

  • Smith-Lemli-Opitz Syndrome (SLOS): A genetic disorder caused by a defect in cholesterol production, leading to multiple birth defects, mental retardation, and various health issues.
  • 7-Dehydrocholesterol (7-DHC): A cholesterol precursor that accumulates in patients with SLOS due to a deficiency in the enzyme that converts it to cholesterol.
  • Electroretinogram (ERG): A test that measures the electrical responses of various cell types in the retina, used to monitor retinal function in SLOS patients.
  • Brainstem Audiometry (ABR): A hearing test that measures the brain's response to sound, used to assess hearing function in SLOS patients.
  • Oxysterols: Oxidized forms of cholesterol that can be toxic to cells, particularly in the nervous system and retina of SLOS patients.
  • FOLFIRINOX: A combination chemotherapy regimen used in the treatment of pancreatic cancer.
  • Reverse Cholesterol Transport (RCT): The process by which HDL (good cholesterol) removes excess cholesterol from tissues and transports it to the liver for elimination.
  • Apolipoprotein: Proteins that bind to lipids (fats) to form lipoproteins, which help transport cholesterol and other fats through the bloodstream.
  • PCSK9: A protein involved in regulating cholesterol levels in the blood by controlling the number of LDL receptors on liver cells.
  • Antioxidants: Substances that can prevent or slow damage to cells caused by free radicals, unstable molecules that the body produces as a reaction to environmental and other pressures.

References

  1. https://clinicaltrials.gov/study/NCT01773278
  2. https://clinicaltrials.gov/study/NCT00001721
  3. https://clinicaltrials.gov/study/NCT04862260
  4. https://clinicaltrials.gov/study/NCT01782027
  5. https://clinicaltrials.gov/study/NCT00272844